Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor

Tenosynovial giant cell tumor is a rare proliferative tumor that arises from the synovium, bursae, or tendon sheaths due to an overproduction of colony-stimulating factor 1. Historically, treatment options for patients with local or diffuse tenosynovial giant cell tumor have been limited to surgical...

Descripción completa

Detalles Bibliográficos
Autores principales: Monestime, Shanada, Lazaridis, Dovena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419392/
https://www.ncbi.nlm.nih.gov/pubmed/32617868
http://dx.doi.org/10.1007/s40268-020-00314-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419392/
https://www.ncbi.nlm.nih.gov/pubmed/32617868
http://dx.doi.org/10.1007/s40268-020-00314-3

Ejemplares similares